Immunohistochemical expression of Ki-67, PCNA and CD34 in astrocytomas: A clinicopathological study

Oman Medical Journal

Volumn 27, Issue 5, 2012, Pages 368-374

  Chaloob, Mohammed Kassim ^a   Ali, Hussam Hasson ^b   Qasim, Ban Jumaa ^c   Mohammed, Ahmed Salahaldeen ^d  

^a Mesan Health office   (Iraq)

^b AL NAHRAIN UNIVERSITY   (Iraq)

^c Al Nahrain University College of Medicine   (Iraq)

^d MINISTRY OF HEALTH   (Iraq)

Author keywords

Astrocytomas; CD34; Ki 67; PCNA

Indexed keywords

CD34 ANTIGEN; CYCLINE; KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGE; AGED; ANGIOGENESIS; ARTICLE; ASTROCYTOMA; CAPILLARY DENSITY; CELL PROLIFERATION; CHILD; FEMALE; GENDER; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PARAMETERS; PATHOLOGY; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

EID: 84867664345     PISSN: 1999768X     EISSN: 20705204     Source Type: Journal    
DOI: 10.5001/omj.2012.93     Document Type: Article

References (47)

1. Mahzouni P, Mokhtari M, Amirmansour B. Differentiation between reactive gliosis and astrocytomas by MIB-1/ki67 immunostaining. JRMS 2007;12(5):241-245.
2. Kumer V, Abbas AK, Fausto N, Mitchell RN. In: Robbins and Cotran, Basic Pathology, 8th ed, Elsevier, Philadelphia, USA, 2007:860-882.
3. Iraqi cancer registry, 2005.
4. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007 Aug;114(2):97-109.
5. Habberstad AH, Gulati S, Torp SH. Evaluation of the proliferation markers Ki-67/MIB-1, mitosin, survivin, pHH3, and DNA topoisomerase IIα in human anaplastic astrocytomas-an immunohistochemical study. Diagn Pathol 2011;6:43.
6. Gözü H, Bilgiç B, Hazneci J, Sargi{dotless}n H, Erkal F, Sargi{dotless}n M, et al. Is Ki-67 index a useful labeling marker for invasion of pituitary adenomas? Turkish Journal of Endocrinology and Metabolism 2005;4:107-113.
7. Ambroise MM, Khosla C, Ghosh M, Mallikarjuna VS, Annapurneswari S. Practical value of MIB-1 index in predicting behavior of astrocytomas. Indian J Pathol Microbiol 2011 Jul-Sep;54(3):520-525.
8. Johannessen AL, Torp SH. The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas. Pathol Oncol Res 2006;12(3):143-147.
9. Bowers DC, Gargan L, Kapur P, Reisch JS, Mulne AF, Shapiro KN, et al. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. J Clin Oncol 2003 Aug;21(15):2968-2973.
10. Malhan P, Husain N, Bhalla S, Gupta RK, Husain M. Proliferating cell nuclear antigen, p53 and micro vessel density: Grade II vs. Grade III astrocytoma. Indian J Pathol Microbiol 2010 Jan-Mar;53(1):20-23.
11. Kayaselçuk F, Zorludemir S, Gümürdülü D, Zeren H, Erman T. PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade. J Clin Oncol 2002;57:115-121.
12. Yu-hong Z, Jie-ying Z, Ai-rong C, Yu-mei M, Heng-shu W, Yue-hong L, et al. Expression and significance of TIP30, VEGF and CD34 in brain astrocytoma. Cancer Research and Clinic 2009;21(7):444-446.
13. Edilson S, Airlane A, Benedito S. Ki-67 and Bcl-2 antigen expression in adenomatous colorectal polyps from women with breast cancer. Society of Surgical Oncology 2010;17(9):2378-2383.
14. Lumachi F, Ermani M, Marino F, Iacobone M, Baldessin M, Cappuzzo G, et al. PCNA-LII, Ki-67 immunostaining, p53 activity and histopathological variables in predicting the clinical outcome in patients with parathyroid carcinoma. Anticancer Res 2006 Mar-Apr;26(2A):1305-1308.
15. Zhang YH, Yang Q, Cui W, Liu YX, Liu SX, Yao X. Correlation of microvascular density and clinicopathological factors in different subtypes of renal cell carcinoma. Zhonghua Zhong Liu Za Zhi 2010 Feb;32(2):117-122.
16. Abdelaziz OS, El-Sabaa BM, Abdelaziz A. Characterization of cancer stem cells in patients with brain astrocytomas: a clinicopathological and immunohistochemical study. Bull Alex Fac Med 2010;46(4):357-363.
17. Rodríguez-Pereira C, Suárez-Peñaranda JM, Vázquez-Salvado M, Sobrido MJ, Abraldes M, Barros F, et al. Value of MIB-1 labelling index (LI) in gliomas and its correlation with other prognostic factors. A clinicopathologic study. J Neurosurg Sci 2000 Dec;44(4):203-210.
18. Isolan GR, Ribas Filho JM, Isolan PM, Giovanini A, Malafaia O, Dini LI, et al. Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins. Arq Neuropsiquiatr 2005 Dec;63(4):997-1004.
19. Liwei Y, Xiuzhen W. Expression and clinical significance of PTEN and Ki-67 in hmnan astrocytoma. Jiangsu Medical Journal 2010;36(5):73-75.
20. Yong-hua R, Guo-ying W, Yi W, Xian Z. Study on the expression of VEGF and Ki-67 related to malignant transformation of astrocytoma. Medicine and Pharmacy of Yunnan 2003;1:18-22.
21. Atik E, Serarslan Y, Bakaris S, Savas N. The importance of proliferative activity and angiogenesis in meningioma and glioma. Turk Neurosurg 2005;15(4):176-181.
22. Huang Y. Expression and significance of hypoxia inducible factor-1α, Ki-67 and microvessel density in diffuse infiltrating astrocytoma. Clin Exp Med 2010;23:51-56.
23. Scott IS, Morris LS, Rushbrook SM, Bird K, Vowler SL, Burnet NG, et al. Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology. Neuropathol Appl Neurobiol 2005 Oct;31(5):455-466.
24. Georgescu CV, Sǎftoiu A, Georgescu CC, Ciurea R, Ciurea T. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma. J Gastrointestin Liver Dis 2007 Jun;16(2):133-139.
25. Ang LC, Plewes M, Tan L, Begley H, Agranovich A, Shul D. Proliferating cell nuclear antigen expression in the survival of astrocytoma patients. Can J Neurol Sci 1994 Nov;21(4):306-310.
26. Ripple H. P53 oncoprotein, PCNA expression and their signification in human astrocytoma. Master's thesis posted on August 19, 2010. In: China Papers (online). Available at: http://mt.china-papers.com. Accessed February 28, 2012.
27. Chu SH, Yuan XH, Jiang PC, Li ZQ, Zhang J, Wen ZH, et al. The expression of hepatocyte growth factor and its receptor in brain astrocytomas. Zhonghua Yi Xue Za Zhi 2005 Mar;85(12):835-838.
28. Lebelt A, Szkudlarek M, Guzińska-Ustymowicz K, Lemancewicz D, Zimnoch L, Dziecioł J. Proliferative activity of chosen central nervous system (CNS) neoplasms. Rocz Akad Med Bialymst 2004;49(Suppl 1):242-243.
29. Yan D, Ling Y, Yu Y, Fulin S, Ming Y, Di JY, et al. Expressions of VEGF, bFGF, PCNA and P53 in human brain astrocytoma. Progress of Anatomical Sciences 2006;12(3):221-223.
30. Li-jun W, Ke X, Guo-guang F. Magnetic resonance spectroscopy of human astrocytoma and the correlation with the expression of Survivin and PCNA. Chinese Journal of Medical Imaging Technology 2008;24:11-15.
31. Bin X, Jun S, Luohe X, Zhimin X. Transforming growth factor α and tumor proliferation cell nuclear antigen in astrocytic tumors. Chinese Journal of Clinical and Experimental Pathology 2006;4:93-97.
32. Maiti AK, Ghosh K, Chatterjee U, Chakrobarti S, Chatterjee S, Basu S. Epidermal growth factor receptor and proliferating cell nuclear antigen in astrocytomas. Neurol India 2008 Oct-Dec;56(4):456-462.
33. Sadanaga H. Immunohistochemical analysis of cell proliferation in gliomas using proliferating cell nuclear antigen. Bull Yamaguchi Med Sch 1994;41(3-4):99-104.
34. Zimnoch L, Kozielec Z, Lewko J, Cylwik B, Mariak Z. Proliferative activity of glial neoplasms of the brain. Neurol Neurochir Pol 1999 Jan-Feb;33(1):87-96.
35. Leon SP, Folkerth RD, Black PM. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 1996 Jan;77(2):362-372.
36. Izycka-Swieszewska E, Rzepko R, Borowska-Lehman J, Stempniewicz M, Sidorowicz M. Angiogenesis in glioblastoma-analysis of intensity and relations to chosen clinical data. Folia Neuropathol 2003;41(1):15-21.
37. Lebelt A, Dziecioł J, Guzińska-Ustymowicz K, Lemancewicz D, Zimnoch L, Czykier E. Angiogenesis in gliomas. Folia Histochem Cytobiol 2008;46(1):69-72.
38. El-Sayed M, Taha MM. Immunohistochemical expression of cycloxygenase-2 in astrocytoma: correlation with angiogenesis, tumor progression and survival. Turk Neurosurg 2011 Jan;21(1):27-35.
39. Yuhong Z, Jie-Ying Z, Ai-Rong C, Yu-Mei M, Heng-Shu M. YueHong L, Wen-Xin W, Xiang-Hong Z. Expression and significance of TIP30, VEGF and CD34 in brain astrocytoma. Cancer Research Clin 2009;21(7):444-449.
40. Zhi-qin C, Xia G, Yan-xia S. Correlation of MMP-9 and FLT-1 expression with microvessel density in astrocytoma. Chinese Journal of Clinical and Experimental Pathology 2008;24:6-9.
41. Fulin S. The correlation study of VEGF, PIGF and children astrocytoma grading and prognosis. Available at http://www.lw23.com/ lunwen_1016637247/. Accessed on 23/11/2011.
42. Jang FF, Wei W, De WM. Vascular endothelial growth factor and basic fibroblast growth factor expression positively correlates with angiogenesis and peritumoural brain oedema in astrocytoma. J Ayub Med Coll Abbottabad 2008 Apr-Jun;20(2):105-109.
43. Mahzouni P, Mohammadizadeh F, Mougouei K, Moghaddam NA, Chehrei A, Mesbah A. Determining the relationship between "microvessel density" and different grades of astrocytoma based on immunohistochemistry for "factor VIII-related antigen" (von Willebrand factor) expression in tumor microvessels. Indian J Pathol Microbiol 2010 Oct-Dec;53(4):605-610.
44. Korkolopoulou P, Christodoulou P, Kouzelis K, Hadjiyannakis M, Priftis A, Stamoulis G, et al. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. Br J Cancer 1997;75(9):1269-1278.
45. Kordek R, Biernat W, Debiec-Rychter M, Alwasiak J, Liberski PP. Comparative evaluation of p53-protein expression and the PCNA and Ki-67 proliferating cell indices in human astrocytomas. Pathol Res Pract 1996 Mar;192(3):205-209.
46. Choi YM, Kim TY, Yoon KJ, Moon HB, Kim JM. A comparative study on MIB-1, AgNORs and PCNA expressions in astrocytic tumors. J Korean Neurosurgery Soc 1997;26(4):476-485.
47. Sallinen PK, Haapasalo HK, Visakorpi T, Helén PT, Rantala IS, Isola JJ, et al. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 1994 Dec;174(4):275-282.